A Whangārei teenager will get the health trip to Melbourne she needs, thanks to the support of Air New Zealand and the ...

Pharmaceutical share prices fell last Monday, after US President Donald Trump vowed to reduce drug prices in the USA by as ...

Carpenter says to watch out for a three to four yard high weed with white flower clusters, and purple spots on the stem.

US biopharma Biohaven has been told by the US Food and Drug Administration (FDA) that the agency is extending the PDUFA date ...

Thousands of videos on social media are promoting the consumption of unpasteurised milk as H5N1 bird flu spreads in British farms ...

Biohaven shares plunged Thursday after the Food and Drug Administration unexpectedly delayed the review date for its rare-disease drug.

Biohaven Ltd. (NYSE:BHVN) shares plunged on Thursday after the Food and Drug Administration (FDA) unexpectedly delayed the ...

Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...

The FDA also changed its tune and is now planning to convene an advisory committee to discuss Biohaven’s application.

The median age at symptom onset in the cohort was 55 years, ranging from 16 to 81 years. Data from patients’ initial ...

Biohaven (BHVN) stock slides as the FDA delays review of its lead drug troriluzole for a neurological condition called ...

Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. - Troriluzole has been granted Fast-Track ...